Rock Springs Capital Management LP Novavax Inc Transaction History

Rock Springs Capital Management LP

$1.47 Billion
Q2 2025

A detailed history of Rock Springs Capital Management LP transactions in Novavax Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 53,900 shares of NVAX stock, worth $457,072. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,900

Previous 650,000 91.71%

Holding current value

$457,072

Previous $4.17 Million 91.86%

% of portfolio

0.02%

Previous 0.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$5.43 - $7.74 $3.24 Million - $4.61 Million	-596,100 Reduced 91.71%	53,900 $339,000
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $267,750 - $427,750	-25,000 Reduced 3.7%	650,000 $8.21 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $534,388 - $2.88 Million	137,375 Added 25.55%	675,000 $8.55 Million
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $528,360 - $844,275	-110,075 Reduced 16.99%	537,625 $2.58 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $755,910 - $1.08 Million	111,000 Added 20.68%	647,700 $4.69 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $8,671 - $12,376	1,300 Added 0.24%	536,700 $3.99 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $16,128 - $34,944	2,800 Added 0.53%	535,400 $3.71 Million
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $590,962 - $1.67 Million	-66,700 Reduced 11.13%	532,600 $5.48 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $2.26 Million - $9.45 Million	124,200 Added 26.14%	599,300 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $975,932 - $2.03 Million	26,900 Added 6.0%	475,100 $24.4 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $1.62 Million - $3.32 Million	23,200 Added 5.46%	448,200 $33 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $4.04 Million - $6.54 Million	-30,000 Reduced 6.59%	425,000 $60.8 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $726,000 - $1.55 Million	-6,000 Reduced 1.3%	455,000 $96.6 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $11.5 Million - $32.7 Million	-102,205 Reduced 18.15%	461,000 $83.6 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $1.77 Million - $3.14 Million	-22,500 Reduced 3.84%	563,205 $62.8 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $1.2 Million - $2.7 Million	15,107 Added 2.65%	585,705 $63.5 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $7.91 Million - $47.7 Million	570,598 New	570,598 $47.6 Million
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $599,625 - $848,250	-162,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $801,125 - $1.98 Million	162,500 New	162,500 $952,000

Others Institutions Holding NVAX

# of Institutions

309

Shares Held

91.7M

Call Options Held

6.17M

Put Options Held

6.95M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $663M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Novavax Inc Transaction History